Societe Francaise de Rhumatologie
12
2
3
6
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 12 trials
100.0%
+13.5% vs industry average
8%
1 trials in Phase 3/4
0%
0 of 6 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (12)
Personalized and Automated Digital Coaching in People With Non-specific Chronic Low Back Pain
Role: collaborator
Study and Monitoring of Early Undifferentiated Arthritis
Role: lead
Efficacy of Microparticle Geniculate Artery Embolization in Total Knee Prosthesis Patients With Pain Resistant to Medical Treatment. A Prospective Randomized Controlled Trial
Role: lead
Observational Study in Patients Treated With JAK Inhibitors for Inflammatory Rheumatism (MAJIK)
Role: lead
Impact of COVID-19 Pandemic and Social Distancing on Mental Health of Chronic Inflammatory Rheumatism Affected Patients
Role: collaborator
Effectiveness of SMS Reminders on Influenza Vaccination Coverage in Patients With RA in the ART Registry
Role: lead
Survey on the Expectations of Adolescents With Juvenile Idiopathic Arthritis (JIA) Regarding Knowledge and Communication With Health Care Professionals in the Field of Sexual Health, and Their Parents' Views on the Subject. (SNAPS-JIA)
Role: collaborator
The ASSESS National Multi-center Prospective Cohort
Role: collaborator
Vasculopathy, Inflammation and Systemic Sclerosis
Role: collaborator
French National Registry: ART REGISTRY (Observational Study)
Role: collaborator
Adaptation Process of Patient-Reported Outcomes, an eVALuation Study
Role: collaborator
Dynamic Humeral Centering in Impingement Syndrome
Role: collaborator
All 12 trials loaded